All In Capital leads pre-seed round in healthcare infrastructure startup Tross
- ByStartupStory | August 20, 2026

Tross has raised an undisclosed amount in a pre-seed funding round led by All in Capital, with participation from DeVC. The healthcare infrastructure startup will use the funding to develop its product, expand its engineering team, add more electronic health record and payer integrations, and grow its presence in the US healthcare market.
Founded by Padam Kataria and Meet Shah, Tross is building the technology layer that allows artificial intelligence companies to connect with the complex systems used by hospitals, doctors, insurers, and other healthcare organisations. The startup was previously known as Ayden.
At first glance, this may sound like a behind-the-scenes technology problem, but it is one of the biggest challenges in healthcare AI. Hospitals and insurers often use different software systems that do not communicate easily with one another. Important information may be spread across electronic health records, payer portals, billing systems, and other platforms.
Tross wants to make it easier for AI agents and healthcare applications to work with these systems. Its API layer is designed to simplify access to fragmented healthcare data and workflows, allowing developers to build products without creating a separate integration for every hospital or payer.
This could help healthcare companies automate tasks such as checking insurance eligibility, accessing patient records, managing claims, and coordinating administrative workflows. However, connecting to healthcare infrastructure is more complicated than connecting to ordinary business software. Data privacy, security, compliance, accuracy, and permission controls all need to be handled carefully.
That is why Tross’s engineering, and integration work will be central to its progress. The company needs to make its platform reliable enough for healthcare organisations while also making it simple for developers to use. Even a small error in a healthcare workflow can create delays, financial losses, or risks for patients.
All In Capital’s investment came through its Golden Ticket programme, which backs up early-stage founders and provides capital alongside access to the US startup ecosystem. The firm highlighted Tross’s early customer validation and the founders’ efforts to understand the problem directly by speaking with healthcare teams in the United States.
For Tross, the funding provides the resources to move from early validation to a more complete product. The company will need to deepen its integrations, win more customers, and prove that its infrastructure can support real healthcare workflows at scale.
If it succeeds, Tross could become an important technology partner for the next generation of healthcare AI companies. Its opportunity lies not in replacing hospitals or doctors, but in making the systems they already use more accessible, connected, and ready for intelligent automation.






